Fampyra® now available in Ireland to treat MS walking impairment
Biogen Idec today announced that Fampyra® (prolonged-release fampridine tablets) has been made available in Ireland for the symptomatic treatment of walking impairment in adults with Multiple Sclerosis (MS). Fampyra is a prescription drug and is licensed for use in all types of the disease, including the progressive forms. FAMPYRA is available by way of retail pharmacy on a private payment basis. Fampyra is not currently available for reimbursement through any of the Health Service Executive’s (HSE’s) payment schemes...... Read More - http://www.ms-uk.org/ampyra
Fampyra® now available in Ireland to treat MS walking
Fampyra® now available in Ireland to treat MS walking
MS-UK - http://www.ms-uk.org/
Re: Fampyra® now available in Ireland to treat MS walking
Fampyra® is a potassium channel blocker.
Magnesium also blocks potassium channels, but as an essential nutrient, it is used by the body for a multitude of purposes as the body sees fit.
People with ms are know to be Mg wasters and. even in the general population, most people are deficient.
THX1138
Magnesium also blocks potassium channels, but as an essential nutrient, it is used by the body for a multitude of purposes as the body sees fit.
People with ms are know to be Mg wasters and. even in the general population, most people are deficient.
THX1138